Generic Name and Formulations:
Rho(D) immune globulin human; 250 IU; per syringe; soln for IM inj.; preservative-free; latex-free.

Company:
Grifols Biologicals, Inc.
Therapeutic Use:Immune-mediated blood disorders
Hematological Disorders Resource Center » Indications for HYPERRHO S/D MINI-DOSE:
Prevention of isoimmunization of Rho(D) negative women during spontaneous or induced abortion of ≤12 weeks' gestation when mother is not sensitized to Rho(D) antigen and father is not known to be Rho(D) negative.

Adult:
Postabortion or miscarriage of up to 12 weeks gestation: 1 syringe IM within 3hrs of spontaneous or induced abortion or within 72hrs following termination of pregnancy.

Children:
Not recommended.

Contraindications:
Neonates.

Warnings/Precautions:
Contains human plasma; monitor for possible infection transmission. IgA deficiency. Pregnancy (Cat.C).

Interactions:
Avoid live vaccines within 3 months.

See Also:
HYPERRHO S/D FULL DOSE

Pharmacological Class:
Immune globulin.

Adverse Reactions:
Local or infusion reactions.

Note:
Report all infections suspected to be transmitted by HyperRHO S/D to (800) 520-2807.

How Supplied:
Full dose (Single-dose prefilled syringe)—1; Mini dose (Single-dose prefilled syringe)—10